Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Freyer

Showing results (201-210 of 258) with videos related to

Pageof 26
Sort By:
JCO Oncology Practice|October 9, 2025
Erratum: Promoting Resilience in Stress Management: A Randomized Controlled Trial of a Novel Psychosocial Intervention for Adolescents and Young Adults With Advanced CancerAbby R Rosenberg, Kaitlyn M Fladeboe, Chuan Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology groupJames B Nachman, Mei K La, Stephen P Hunger, et al.
JCO Oncology Practice|April 28, 2025
Promoting Resilience in Stress Management: A Randomized Controlled Trial of a Novel Psychosocial Intervention for Adolescents and Young Adults With Advanced CancerAbby R Rosenberg, Kaitlyn M Fladeboe, Chuan Zhou, et al.
Pediatric Blood & Cancer|September 24, 2022
Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse eventsShana S Jacobs, Janice S Withycombe, Sharon M Castellino, et al.
The Lancet. Oncology|December 5, 2016
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trialDavid R Freyer, Lu Chen, Mark D Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology GroupJoann L Ater, Tianni Zhou, Emiko Holmes, et al.
JNCI Cancer Spectrum|September 29, 2021
Project Forward: A Population-Based Cohort Among Young Adult Survivors of Childhood CancersJoel Milam, David R Freyer, Kimberly A Miller, et al.
Pediatric Blood & Cancer|January 22, 2013
The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology cliniciansBryce B Reeve, Janice S Withycombe, Justin N Baker, et al.
Journal of the National Cancer Institute|January 31, 2020
Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse EventsBryce B Reeve, Molly McFatrich, Jennifer W Mack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology GroupEric J Chow, Barbara L Asselin, Cindy L Schwartz, et al.
Pageof 26

Showing results (201-210 of 258) with videos related to

Sort By:
Pageof 26
JCO Oncology Practice|October 9, 2025
Erratum: Promoting Resilience in Stress Management: A Randomized Controlled Trial of a Novel Psychosocial Intervention for Adolescents and Young Adults With Advanced CancerAbby R Rosenberg, Kaitlyn M Fladeboe, Chuan Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology groupJames B Nachman, Mei K La, Stephen P Hunger, et al.
JCO Oncology Practice|April 28, 2025
Promoting Resilience in Stress Management: A Randomized Controlled Trial of a Novel Psychosocial Intervention for Adolescents and Young Adults With Advanced CancerAbby R Rosenberg, Kaitlyn M Fladeboe, Chuan Zhou, et al.
Pediatric Blood & Cancer|September 24, 2022
Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse eventsShana S Jacobs, Janice S Withycombe, Sharon M Castellino, et al.
The Lancet. Oncology|December 5, 2016
Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trialDavid R Freyer, Lu Chen, Mark D Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology GroupJoann L Ater, Tianni Zhou, Emiko Holmes, et al.
JNCI Cancer Spectrum|September 29, 2021
Project Forward: A Population-Based Cohort Among Young Adult Survivors of Childhood CancersJoel Milam, David R Freyer, Kimberly A Miller, et al.
Pediatric Blood & Cancer|January 22, 2013
The first step to integrating the child's voice in adverse event reporting in oncology trials: a content validation study among pediatric oncology cliniciansBryce B Reeve, Janice S Withycombe, Justin N Baker, et al.
Journal of the National Cancer Institute|January 31, 2020
Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse EventsBryce B Reeve, Molly McFatrich, Jennifer W Mack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2015
Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology GroupEric J Chow, Barbara L Asselin, Cindy L Schwartz, et al.
Pageof 26